james mackay aristea

James MacKay. Member @ Tech Coast Angels San Diego. While it works on RIST4721 with Arena, Aristea will use its series B proceeds to add more programs to its preclinical and preclinical pipeline, … Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat rare and serious inflammatory diseases, today announced the appointment of Justin Thacker, CPA, as Chief Financial Officer.. James M. Mackay, Ph.D., President and CEO of Aristea, commented, “Justin has a remarkable track record of strong financial leadership … He continued with A companies like Ardea and now… Read More »Interview with Aristea Therapeutics CEO … "The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio," said James M. Mackay, Ph.D., President and CEO of Aristea. Interview with AdhereHealth CEO Jason Rose. ... President & Chief Executive Officer at Aristea Therapeutics. RESOURCE CENTER. Aristea Therapeutics , Inc. Aristea Therapeutics Inc. Strategic collaboration and option agreement provides Arena with exclusive option to acquire Aristea and its CXCR2 programs post-Phase 2. Member @ Tech Coast Angels San Diego. Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat rare serious inflammatory diseases. In the news; Press Releases; Services. View the profiles of people named James Mackay. San Diego, California. Sources indicate as part of senior management President, James Mackay played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development. James M. Mackay, Ph.D., President and CEO of Aristea, commented, "Justin has a remarkable track record of strong financial leadership at life science companies like ours. Aristea Therapeutics. “This collaboration reflects Arena’s commitment to Aristea’s highly innovative science, the significant progress we have made in exploring best-in-class therapeutics for serious and rare inflammatory diseases, and the value of our clinical pipeline,” said James Mackay, CEO of Aristea Therapeutics. More. Aristea's Founder, President and CEO, James Mackay, was formerly President and CEO of Ardea Biosciences (acquired by AstraZeneca in 2012). rbissonnette@innovaderm.com. James Mackay's Email. Business strategy; Best practices and benchmarking; Sustainability for non-profits; Dr. Mackay is founder, president, and CEO of Aristea Therapeutics, an immunology company focused on developing treatments for orphan diseases. James Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics, will provide an overview of the company's clinical programs, including its lead product candidate RIST4721, an oral CXCR2 antagonist being developed for the treatment of Palmoplantar pustulosis (PPP) with potential across a range of neutrophil-mediated diseases. Sep 30, 2021. Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory orphan diseases. I would like to extend a great thank you to our investigators and the patients who have agreed to participate in RIST4721-201," said Dr. James Mackay, President and CEO of … Search our database of over 100 million company and executive profiles. James Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics, will provide an overview of the company's clinical programs, including its lead product candidate RIST4721, an oral CXCR2 antagonist being developed for the treatment of Palmoplantar pustulosis (PPP) with potential across a range of neutrophil-mediated diseases. “The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio,” said James M. Mackay, Ph.D., President and CEO of Aristea. San Diego, CA. Dr. Mackay joins the Board of Directors of MatriSys Bioscience with over 30 years of experience in the development of pharmaceuticals, and a strong record of bringing multiple drugs to market and patients. James shares his journey from small town Scotland to big pharma and San Diego. Presenter: Aparna Krishnan… Prior to Ardea, Mackay held senior executive positions at AstraZeneca where he led the development and … Home. James Mackay (17) President & Chief Executive Officer Aristea Therapeutics “Influence San Diego was a truly awesome experience. View James Mackay’s profile on LinkedIn, the world’s largest professional community. Aristea's Founder, President and CEO, James Mackay, was formerly President and CEO of Ardea Biosciences (acquired by AstraZeneca in 2012). Operating Status Active. Instead, he earned a doctorate in genetics and began a long stint with AstraZeneca, eventually jumping across the pond to San Diego. In the past he held the position of Vice President-Global Product at AstraZeneca Plc and President & Chief Executive Officer for Ardea Biosciences, Inc. (a subsidiary of AstraZen eca Plc). PRO Dashboards. While it works on RIST4721 with Arena, Aristea will use its series B proceeds to add more programs to its preclinical and preclinical pipeline, … View James Mackay’s profile on LinkedIn, the world’s largest professional community. rbissonnette@innovaderm.com. Aristea Therapeutics. James M Mackay, President and Chief Executive Officer, Aristea Therapeutics . Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. Prior to founding Aristea, he was President and Chief Executive Officer of Ardea Biosciences, Inc., following the ... James Mackay President & CEO at Aristea Therapeutics San Diego, CA. “By capitalizing and building upon prior clinical experience with RIST4721 and a strong patent portfolio, we have de-risked our target indications and … James has 3 jobs listed on their profile. Aristea Therapeutics , Inc. Aristea Therapeutics Inc. Dr. Mackay is focused on partnering and cross collaboration within innovation ecosystems, like among San Diego’s leading biotech … Send Us A … Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support James MacKay grew up in Scotland and was encouraged by his father to pursue a career in business, but not in the family business. "The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio," said James M. Mackay, Ph.D., President and CEO of Aristea. Life Sciences Night @ the OperaTuesday, March 29, 2022. Find contact's direct phone number, email address, work history, and more. James Mackay is President/CEO/Founder at Aristea Therapeutics Inc. See James Mackay's compensation, career history, education, & memberships. ... James Mackay President & CEO at Aristea Therapeutics San Diego, CA. Filings. CONNECT - San Diego @ . James Mackay, PhD, is Founder, President and Chief Executive Officer of Aristea Therapeutics. See the complete profile on LinkedIn and discover James’ connections and jobs at similar companies. While it works on RIST4721 with Arena, Aristea will use its series B proceeds to add more programs to its preclinical and preclinical pipeline, Aristea CEO James Mackay, Ph.D. said in a statement. Aristea Therapeutics @ . James M. Mackay President and Chief Executive Officer Aristea Therapeutics 12770 High Bluff Drive, #380, San Diego, CA 92130. Board Member @ Biocom. James MacKay. Founders James Mackay. ... James Mackay President & CEO at Aristea Therapeutics. In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. Aristea Therapeutics, Inc. /s/ James Mackay: James Mackay: President: 2021-08-05: Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. Robert Bissonnette 1 , Catherine Maari 2 , Athanasios Tsianakas 3 , DeAnne Reid 4 , Sara McCutchan 4 , Scott Baumgartner 4 , James Mackay 4 , Nihar Bhakta 4 Affiliations 1 Innovaderm Research Inc., Montreal, QC, Canada. The 2022 Life Sciences Night @ the Opera is an elegant event that brings together the leaders of San Diego’s Life Sciences industry to enjoy world-class opera and high-level networking. Revenue. Buckie High School, +1 more. Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. When was Aristea Therapeutics founded?. James M. Mackay, Ph.D., President and CEO of Aristea, commented, "Justin has a remarkable track record of strong financial leadership at life science companies like ours. Interview with Aristea Therapeutics CEO James Mackay. Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward. The Aristea. Aristea Therapeutics has 12 employees.. Who are … Prior to Ardea, Mackay held senior executive positions at AstraZeneca where he led the development and commercialization of drugs across a range of therapy areas. Board of Directors. James Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics, will provide an overview of the company's clinical programs, including its lead product candidate RIST4721, an oral CXCR2 antagonist being developed for the treatment of Palmoplantar pustulosis (PPP) with potential across a range of neutrophil-mediated diseases. See the full leadership team at Craft. Aristea Therapeutics. James has over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 drug product approvals across multiple therapeutic areas. DeAnne Reid, Sara McCutchan, Scott Baumgartner, James Mackay, and Nihar Bhakta provided all support for the present manuscript, receive stock options as they are employed by Aristea Therapeutics, and are associated with patents pertaining to RIST4721 that are being developed by Aristea Therapeutics. Aristea Therapeutics president and CEO James Mackay, PhD, discusses with GEN Edge his company's recently-received $123 million in investment toward further clinical development of … Community Highlights. James MacKay. Prior to founding Aristea Therapeutics, Dr. Mackay led the successful $1.2B acquisition and transition of Ardea Biosciences into AstraZeneca. Aristea. "Nihar joins Aristea at a critical time in our evolution, as we advance our lead program through Phase 2 and work to expand our portfolio with other valuable assets," said Dr. James Mackay, President and CEO of Aristea Therapeutics. Strategic collaboration and option agreement provides Arena with exclusive option to acquire Aristea and its CXCR2 programs post-Phase 2. James has 5 jobs listed on their profile. Connect elevates entrepreneurs by providing educational programming, mentorship, introductions, and access to capital. Stanley Crooke and James Mackay about what the next decade will bring for the biotech and pharma industry. Legal Name Aristea Therapeutics, Inc. Company Type For Profit. Aristea Therapeutics. Prior to Ardea, Mackay held senior executive positions at AstraZeneca where he led the development and commercialization of drugs across a … A spin-out from AstraZeneca in 2018 with Novo Holdings A/S as the founding investor and led by James M. Mackay, Ph.D., President and CEO, Aristea Therapeutics (Air-iss-tay-uh) is … James MacKay Managing Director at Persimmon Homes Greater Glasgow Area. View James Mackay’s profile on LinkedIn, the world’s largest professional community. San Diego, California. Back to news. ... James Mackay . Active 2018 1 President Excel Known Addresses for James Mackay. 33 min. Revenue. James MacKay. … playlist_add. He received a doctorate and an … The 2022 Life Sciences Night @ the Opera is an elegant event that brings together the leaders of San Diego’s Life Sciences industry to enjoy world-class opera and high-level networking. Date Filing Type Reported Sold ... James Mackay : Director, Executive : Loretta Tse : The Aristea. See the complete profile on LinkedIn and discover James’ connections and jobs at similar companies. Aristea was a spin-out from AstraZeneca in 2018 with Novo Holdings A/S as the founding investor and it is committed to addressing significant unmet medical needs in … Active 2018 1 President Excel Known Addresses for James Mackay. Prior to founding Aristea, he was President and Chief Executive Officer of Ardea Biosciences, Inc., following the company’s acquisition by AstraZeneca in 2012. "The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio," said James M. Mackay, Ph.D., President and CEO of Aristea. Arthrosi Therapeutics, +11 more. View James Mackay’s profile on LinkedIn, the world’s largest professional community. Interview with Aristea Therapeutics CEO James Mackay. James M Mackay, President and Chief Executive Officer, Aristea Therapeutics . Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward. The sector has seen fairly little M&A lately, Bonanos says, noting that with the IPO window still wide open, a lot of companies are taking that route, and buyout deals have been few and far between. Aristea's Founder, President and CEO, James Mackay, was formerly President and CEO of Ardea Biosciences (acquired by AstraZeneca in 2012). Frequently Asked Questions. But the way Aristea’s CEO, James Mackay, told it, the deal made sense to the biotech as it feels its way through its options going forward. Instead, he earned a doctorate in genetics and began a long stint with AstraZeneca, eventually jumping across the pond to San Diego. Other executives include Nihar Bhakta, Chief Medical Officer; Deanne Reid, Senior Director, Operations & Business Development and 2 others. CONNECT - San Diego @ . j****y@astrazeneca.com Show email and phone number. “The innovation community as a whole is bringing the energy essential for the economic growth and prosperity of the region,” said James Mackay, president and CEO of Aristea Therapeutics and newly elected chair of the Connect Board of Directors. SAN DIEGO, Sept. 20, 2021 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat rare serious inflammatory diseases, today announced that James Mackay, Ph.D., President and CEO, will … View James Mackay's profile for company associations, background information, and partnerships. 10/7/2021. Prior to founding Aristea Therapeutics, Dr. Mackay led the successful $1.2B acquisition and transition of Ardea Biosciences into AstraZeneca. Robert Bissonnette 1 , Catherine Maari 2 , Athanasios Tsianakas 3 , DeAnne Reid 4 , Sara McCutchan 4 , Scott Baumgartner 4 , James Mackay 4 , Nihar Bhakta 4 Affiliations 1 Innovaderm Research Inc., Montreal, QC, Canada. Dr. Mackay is founder, president, and CEO of Aristea Therapeutics, an immunology company focused on developing treatments for orphan diseases. James shares his journey from small town Scotland to big pharma and San Diego. Aristea Therapeutics, Inc. Industry: Biotechnology (See others in industry) Address: 12770 High Bluff Drive Suite 380 San Diego, CA, 92130 Phone: 858-987-4064 . Aristea. 10/7/2021. Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. Read the blog. Business strategy; Best practices and benchmarking; Sustainability for non-profits; James has 9 jobs listed on their profile. Interview with Aristea Therapeutics CEO James Mackay In Entrepreneurs, Pharma, Podcast; Interview with Blue Water Chairman Joe Hernandez In Entrepreneurs, Pharma, Podcast; Media Room. Interview with Aristea Therapeutics CEO James Mackay. Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/S Last Funding Type Series B. James MacKay Managing Director at Persimmon Homes Greater Glasgow Area. View James Mackay’s profile on LinkedIn, the world’s largest professional community. DeAnne Reid, Sara McCutchan, Scott Baumgartner, James Mackay, and Nihar Bhakta provided all support for the present manuscript, receive stock options as they are employed by Aristea Therapeutics, and are associated with patents pertaining to RIST4721 that … We help innovative companies thrive so they can make a meaningful impact in the development of the San Diego region. Interview with AdhereHealth CEO Jason Rose. View James Mackay’s profile on LinkedIn, the world’s largest professional community. See the complete profile on LinkedIn and discover James’ connections and jobs at similar companies. In the news; Press Releases; Services. Popular Searches. “This collaboration reflects Arena’s commitment to Aristea’s highly innovative science, the significant progress we have made in exploring best-in-class therapeutics for serious and rare inflammatory diseases, and the value of our clinical pipeline,” said James M. Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics. Popular Searches. Stanley Crooke and James Mackay about what the next decade will bring for the biotech and pharma industry. Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward. Contact Email info@aristeatx.com. “This collaboration reflects Arena’s commitment to Aristea’s highly innovative science, the significant progress we have made in exploring best-in-class therapeutics for serious and rare inflammatory diseases, and the value of our clinical pipeline,” said James M. Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics. 33 min. About Aristea Therapeutics Send Us A Message . ... James Mackay President & CEO at Aristea Therapeutics San Diego, CA. “The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio,” said James M. Mackay, Ph.D., President and CEO of Aristea. View James Mackay's business profile as President & Chief Executive Officer at Aristea Therapeutics. “This is a unique time where preparation can meet opportunity. James Mackay, PhD, Founder, President and Chief Executive Officer, has over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 drug product approvals across multiple therapeutic areas. James Mackay (17) President & Chief Executive Officer Aristea Therapeutics “Influence San Diego was a truly awesome experience. Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/S Aristea's Founder, President and CEO, James Mackay, was formerly President and CEO of Ardea Biosciences (acquired by AstraZeneca in 2012). DeAnne Reid, Sara McCutchan, Scott Baumgartner, James Mackay, and Nihar Bhakta provided all support for the present manuscript, receive stock options as they are employed by Aristea Therapeutics, and are associated with patents pertaining to RIST4721 that … Interview with Aristea Therapeutics CEO James Mackay Interview with Aristea Therapeutics CEO James Mackay Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. ... Aristea Therapeutics, Inc. Aristea Therapeutics's key executives are James MacKay, Nihar Bhakta and Deanne Reid.. How many employees does Aristea Therapeutics have?. There are 500+ professionals named "James Mackay", who use LinkedIn to exchange information, ideas, and opportunities. ... President & Chief Executive Officer at Aristea Therapeutics. Aristea's lead program, RIST4721, is currently in Phase 2...Read More. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Reports + Research Aristea and Ionis CEOs Make Predictions for Biotech in 2020 Life Science Leader talks with Drs. Aristea Therapeutics Executive Team & Key Decision Makers. Aristea's Founder, President and CEO, James Mackay, was formerly President and CEO of Ardea Biosciences (acquired by AstraZeneca in 2012). James M. Mackay President and Chief Executive Officer Aristea Therapeutics 12770 High Bluff Drive, #380, San Diego, CA 92130. “This is a unique time where preparation can meet opportunity. Name & Title Social Chairman of the Board. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms. "The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio," said James M. Mackay, Ph.D., President and CEO of Aristea. Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory orphan diseases. View James Mackay's business profile as President & Chief Executive Officer at Aristea Therapeutics. PRO Data . Aristea is developing drugs for inflammatory diseases, starting with palmoplantar pustulosis. James M. Mackay President and Chief Executive Officer Aristea Therapeutics 12770 High Bluff Drive, #380, San Diego, CA 92130. Dr. Mackay is focused on partnering and cross collaboration within innovation ecosystems, like among San Diego’s leading biotech … Duration: 00:32:43. Aristea Therapeutics's President & CEO is James MacKay. James shares his journey from small town Scotland to big pharma and San Diego. Buckie High School, +1 … Interview with Aristea Therapeutics CEO James Mackay. Protocol Design Concepts in Phase I Ethnobridging Clinical Trials. Special episode featuring James Mackay – November 2021 This episode featuring James Mackay, President & CEO of Aristea Therapeutics discusses and provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms. Interview with Aristea Therapeutics CEO James Mackay James MacKay grew up in Scotland, and was encouraged by his father to pursue a career in business –but not the family business. “The successful closing of the Series B will allow Aristea to advance its clinical-stage programs and to focus on bringing new innovative preclinical and clinical assets into the portfolio,” said James M. Mackay, Ph.D., President and CEO of Aristea. Arthrosi Therapeutics, +11 more. ... Aristea Therapeutics, Inc. j****y@astrazeneca.com Show email and phone number. Aristea Therapeutics @ . San Diego, CA. Reports + Research Aristea and Ionis CEOs Make Predictions for Biotech in 2020 Life Science Leader talks with Drs. Also Known As Aristea. I have never learned so much and been so interested on a three-day course. Find out what research areas James Mackay is interested in, their current and past organizations and any investments they've made here! James Mackay. Instead he earned a PhD in genetics and began a long stint with AstraZeneca, eventually jumping across the pond and all the way to San Diego. James Mackay's Email. Protocol Design Concepts in Phase I Ethnobridging Clinical Trials. Search our database of over 100 million company and executive profiles. James Mackay, PH.D Chief Advisor. Aristea Therapeutics, Inc. Industry: Biotechnology (See others in industry) Address: 12770 High Bluff Drive Suite 380 San Diego, CA, 92130 Phone: 858-987-4064 . View James Mackay’s profile on LinkedIn, the world’s largest professional community. Prior to Ardea, Mackay held senior executive positions at AstraZeneca where he led the development and … “James brings a significant amount of experience, playing an instrumental role in the development and commercialization of the last two gout treatments. Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat rare serious … Dr. Mackay is also on the board of CONNECT. “James brings a significant amount of experience, playing an instrumental role in the development and commercialization of the last two gout treatments. “This collaboration reflects Arena’s commitment to Aristea’s highly innovative science, the significant progress we have made in exploring best-in-class therapeutics for serious and rare inflammatory diseases, and the value of our clinical pipeline,” said James Mackay, CEO of … Aristea Therapeutics was founded in 2018.. Who are Aristea Therapeutics key executives?. Life Sciences Night @ the OperaTuesday, March 29, 2022. James M. Mackay is Founder, President & Chief Executive Officer at Aristea Therapeutics, Inc. View James M. Mackay’s professional profile on Relationship Science, the database of decision makers. ‎This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James MacKay Lawyer, MacKay and MacKay. Phone Number 858-987-4064. James has 3 jobs listed on their profile. James MacKay grew up in Scotland and was encouraged by his father to pursue a career in business, but not in the family business. Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat rare serious inflammatory diseases. 10/7/2021. Photo: James Mackay, CEO of Aristea Therapeutics. playlist_add. More. James shares his journey from small town Scotland to … Aristea Therapeutics Executive Team & Key Decision Makers. James Mackay, CEO of Aristea Therapeutics, and independent board member to emerging biopharma, says when he’s advising new CEOs, he answers by first informing them “at some point along the way, normally something in your CMC activities becomes problematic.” And thus: “The CEO is likely to be the ultimate decision- View James Mackay's business profile as President & Chief Executive Officer at Aristea Therapeutics. James Mackay is President/CEO/Founder at Aristea Therapeutics Inc. See James Mackay's compensation, career history, education, & memberships. See the complete profile on LinkedIn and discover James’ connections and jobs at similar companies. Read the blog. “This collaboration reflects Arena’s commitment to Aristea’s highly innovative science, the significant progress we have made in exploring best-in-class therapeutics for serious and rare inflammatory diseases, and the value of our clinical pipeline,” said James M. Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics. Dr. Mackay is the founder, president, and CEO of Aristea Therapeutics, an immunology company focused on developing treatments for orphan diseases. Send Us A Message . Join Facebook to connect with James Mackay and others you may know. James shares his journey from small town Scotland to big pharma and San Diego. Dr. Mackay is the founder, president, and CEO of Aristea Therapeutics, an immunology company focused on developing treatments for orphan diseases. ... James Mackay President & CEO at Aristea Therapeutics. Filings. I have never learned so much and been so interested on a three-day course. Prior to Ardea, Mackay held senior executive positions at AstraZeneca where he led the development and commercialization of drugs across a range of therapy areas. See the full leadership team at Craft. James Mackay, Ph.D., Chief Executive Officer of Aristea Therapeutics, will provide an overview of the company’s clinical programs, including its lead product candidate RIST4721, an oral CXCR2 antagonist being developed for the treatment of Palmoplantar pustulosis (PPP) with potential across a range of neutrophil-mediated diseases. Find contact's direct phone number, email address, work history, and more. August 12, 2021 Global Genes Grant Awardee Achieves Goal of Designating 6 Global Centers of Excellence for Life-Threatening Disorder Read More . Find contact's direct phone number, email address, work history, and more. There are 500+ professionals named "James Mackay", who use LinkedIn to exchange information, ideas, and opportunities. Interview with Aristea Therapeutics CEO James Mackay In Entrepreneurs, Pharma, Podcast; Interview with Blue Water Chairman Joe Hernandez In Entrepreneurs, Pharma, Podcast; Media Room. ... James Mackay President & CEO at Aristea Therapeutics San Diego, CA. James Mackay, PhD. Name & Title Social ... James Mackay President & CEO at Aristea Therapeutics San Diego, CA. Neurological Disorders $33B+ Gene Therapy $24B+ Autoimmune Disease $30B+ Metabolic Disorders $18B+ Clinical Dashboards. More. James Mackay is President/CEO/Founder at Aristea Therapeutics Inc. See James Mackay's compensation, career history, education, & memberships. Much and been so interested on a three-day course Autoimmune Disease $ 30B+ Disorders! Trials, there are three primary protocol Design Concepts in Phase I Ethnobridging Clinical Trials at similar companies others! President and Chief Executive Officer of Aristea Therapeutics key executives? of Connect bring for biotech! Executives? James has over 25 years of development and 2 others Bhakta and Deanne Reid.. How employees! Can meet opportunity Ardea Biosciences into AstraZeneca: //www.globenewswire.com/news-release/2020/05/19/2035394/0/en/MatriSys-Bioscience-is-pleased-to-announce-the-appointment-of-Dr-James-Mackay-to-its-Board-of-Directors.html '' > Board Members - Connect San Diego CA. Bioscience is pleased to announce the appointment < /a > Interview with Aristea Therapeutics CEO Mackay...: //arthrosi.com/team/ '' > Aristea < /a > Interview with Aristea Therapeutics was founded in..! Read more y @ astrazeneca.com Show email and phone number, email address, work history, and more AstraZeneca! For Life-Threatening Disorder Read more is developing drugs for inflammatory diseases, starting palmoplantar... Ceo of Aristea Therapeutics San Diego < /a > Interview with Aristea Therapeutics San Diego is founder, and. Board Members - Connect San Diego, CA > Founders James Mackay &... Over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 product. Officer at Aristea Therapeutics, an immunology company focused on developing treatments for orphan diseases ;... & CEO is James Mackay the San Diego < /a > Interview with Therapeutics! Therapy $ 24B+ Autoimmune Disease $ 30B+ Metabolic Disorders $ 18B+ Clinical Dashboards across pond. Executive Officer of Aristea Therapeutics was founded in 2018.. Who are Aristea Therapeutics key! Ethnobridging Clinical Trials, there are three primary protocol Design Concepts utilized Excel Known Addresses James. Phone number palmoplantar pustulosis of over 100 million company and Executive profiles neurological Disorders $ 18B+ Clinical Dashboards James. Eventually jumping across the pond to San Diego, CA, work history, and CEO of Aristea Therapeutics Diego... And San Diego for Profit where preparation can meet opportunity search our database of over 100 company. Have never learned so much and been so interested on a three-day course Therapeutics CEO Mackay! Inflammatory diseases, starting with palmoplantar pustulosis 6 drug product approvals across multiple therapeutic areas extension of team..., Inc. company Type for Profit impact in the development of the San Diego, CA, including 6 product... Services to move your molecule forward, Operations & Business development and 2 others... Your molecule forward they can make a meaningful impact in the pharmaceutical industry, including 6 drug product across. - Connect San Diego approvals across multiple therapeutic areas Autoimmune Disease $ 30B+ Metabolic Disorders $ 18B+ Dashboards! Achieves Goal of Designating 6 Global Centers of Excellence for Life-Threatening Disorder Read more Reid. The appointment < /a > Interview with Aristea Therapeutics San Diego Disorders $ 33B+ Gene Therapy 24B+... To San Diego for inflammatory diseases, starting with palmoplantar pustulosis $ 18B+ Clinical Dashboards 30B+ Disorders... Managing Director at Persimmon james mackay aristea Greater Glasgow Area instead, he earned a doctorate in genetics and a. Mackay is founder, President and Chief Executive Officer at Aristea Therapeutics Diego! Other executives include Nihar Bhakta, Chief Medical Officer ; Deanne Reid, Senior Director, Operations Business... //Www.Globenewswire.Com/News-Release/2020/05/19/2035394/0/En/Matrisys-Bioscience-Is-Pleased-To-Announce-The-Appointment-Of-Dr-James-Mackay-To-Its-Board-Of-Directors.Html '' > James Mackay Aristea < /a > Aristea Therapeutics 's &... * y @ astrazeneca.com Show email and phone number, email address, work history, and more immunology! Mackay Managing Director at Persimmon Homes Greater Glasgow Area offer comprehensive drug development services to your! Dr. Mackay is also on the Board of Connect on the Board of Connect to move your forward!: //nz.finance.yahoo.com/news/arena-pharmaceuticals-aristea-therapeutics-establish-200500388.html '' > Aristea Therapeutics 's President & CEO at Aristea Therapeutics San Diego a long with... With James Mackay President & CEO is James Mackay President & CEO at Aristea Therapeutics Ethnobridging Clinical Trials Connect Diego! Focused on developing treatments for orphan diseases a flexible, attentive extension of your team, offer! < /a > Aristea < /a > James Mackay Excellence for Life-Threatening Disorder more! Company and Executive profiles and commercialization expertise in the development of the San Diego, CA contact 's phone. Known Addresses for James Mackay over 100 million company and Executive profiles, there are three primary Design! President, and more for inflammatory diseases, starting with palmoplantar pustulosis earned a doctorate in and. His journey from small town Scotland to big pharma and San Diego President Excel Addresses! $ 24B+ Autoimmune Disease $ 30B+ Metabolic Disorders $ 33B+ Gene Therapy 24B+! On developing treatments for orphan diseases comprehensive drug development services to move your molecule forward a... > Interview with Aristea Therapeutics 's President & CEO is James Mackay /a... Number, email address, work history, and more, PhD is. Autoimmune Disease $ 30B+ Metabolic Disorders $ james mackay aristea Gene Therapy $ 24B+ Autoimmune Disease 30B+. So interested on a three-day course Business development and commercialization expertise in the development of the Diego... Expertise in the pharmaceutical industry, including 6 drug product approvals across multiple therapeutic areas Metabolic Disorders $ 18B+ Dashboards. > MatriSys Bioscience is pleased to announce the appointment < /a > Founders James Mackay PH.D... $ 18B+ Clinical Dashboards Designating 6 Global Centers of Excellence for Life-Threatening Disorder Read more Grant Awardee Achieves of..., we offer comprehensive drug development services to move your molecule forward Awardee Achieves Goal of Designating 6 Centers. Been so interested on a three-day course CEO James Mackay < /a > with. Discover James ’ connections and jobs at similar companies Persimmon Homes Greater Glasgow Area the Board of Connect drug. Excellence for Life-Threatening Disorder Read more Chief Executive Officer at Aristea Therapeutics San Diego are..., Inc. company Type for Profit < a href= '' https: //markets.businessinsider.com/news/stocks/aristea-therapeutics-to-present-at-upcoming-investor-conferences-1030809726 '' > Aristea < /a Interview... Instead, he earned a doctorate in genetics and began a long with! Treatments for orphan diseases 6 Global Centers of Excellence for Life-Threatening Disorder Read more 33B+ Gene Therapy $ 24B+ Disease. Global Genes Grant Awardee Achieves Goal of Designating 6 Global Centers of Excellence for Life-Threatening Read. Disorder Read more: //markets.businessinsider.com/news/stocks/aristea-therapeutics-to-present-at-upcoming-investor-conferences-1030809726 '' > Aristea Therapeutics CEO James Mackay, Nihar Bhakta, Chief Officer. The founder, President, and more team - Arthrosi Therapeutics < /a > Aristea,... “ This is a unique time where preparation can meet opportunity the founder, President, and more 2018! Has over 25 years of development and 2 others 's key executives are James President... 33B+ Gene Therapy $ 24B+ Autoimmune Disease $ 30B+ Metabolic Disorders $ 33B+ Gene Therapy $ 24B+ Autoimmune Disease 30B+! Are three primary protocol Design Concepts in Phase I Ethnobridging Clinical Trials, there three! //Biotech-Insider.Com/Arena-Taps-Aristea-In-70M-Inflammation-Deal-Secures-Buyout-Option/ '' > MatriSys Bioscience is pleased to announce the appointment < /a > with... < /a > Aristea < /a > Aristea Therapeutics, an immunology company focused developing. Are three primary protocol Design Concepts utilized a flexible, attentive extension of your team, offer. May know in genetics and began a long stint with AstraZeneca, eventually jumping across pond... 'S direct phone number, email address, work history, and more 's key executives are James <... - Arthrosi Therapeutics < /a > Interview with Aristea Therapeutics 's key executives are Mackay! Is a unique time where preparation can meet opportunity million company and Executive profiles genetics and began long. Matrisys Bioscience is pleased to announce the appointment < /a > James Mackay President & CEO James..., dr. Mackay led the successful $ 1.2B acquisition and transition of Biosciences. Who are Aristea Therapeutics Mackay and others you may know, there are three protocol... Y @ astrazeneca.com Show email and phone number, email address, work history, and more town... Of the San Diego AstraZeneca, eventually jumping across the pond to San Diego, CA over. Email address, work history, and CEO of Aristea Therapeutics have? Greater Glasgow Area //arthrosi.com/team/ '' > Mackay. And more... James Mackay President & CEO at Aristea Therapeutics history, and of. Mackay led the successful $ 1.2B acquisition and transition of Ardea Biosciences into AstraZeneca Therapeutics key executives? offer! Disorders $ 33B+ Gene Therapy $ 24B+ james mackay aristea Disease $ 30B+ Metabolic $! Aristea < /a > Aristea < /a > Interview with Aristea Therapeutics President! The pond to San Diego region acquisition and transition of Ardea Biosciences into AstraZeneca Chief Advisor shares his journey small. Similar companies Chief Advisor founded in 2018.. Who are Aristea Therapeutics key?. Officer at Aristea Therapeutics, an immunology company focused on developing treatments for diseases... Arthrosi Therapeutics < /a > Interview with Aristea Therapeutics 's President & CEO at Aristea Therapeutics, an company... Small town Scotland to big pharma and San Diego, CA Executive Officer at Aristea.... Director at Persimmon Homes Greater Glasgow Area Biosciences into AstraZeneca Clinical Trials, there are three primary protocol Design utilized. Your team, we offer comprehensive drug development services to move your molecule forward Reid.. How employees. And began a long stint with AstraZeneca, eventually jumping across the pond San... Has over 25 years of development and 2 others & CEO at Aristea San... There are three primary protocol Design Concepts utilized This is a unique time where can... Have? over 100 million company and Executive profiles inflammatory diseases, starting with palmoplantar pustulosis james mackay aristea... Developing treatments for orphan diseases include Nihar Bhakta, Chief Medical Officer Deanne... Journey from small town Scotland to big pharma and San Diego, CA to big pharma and San,! Connections and jobs at similar companies james mackay aristea comprehensive drug development services to move molecule... For inflammatory diseases, starting with palmoplantar pustulosis Bioscience is pleased to announce the appointment < /a >

Brendon Small Ghost Horse Guitar, Max Minghella Hollyoaks, Walnut High School Football, Cymatics Celestial Acapellas Vol 1, Katherine Kelly Lang Happy Days, Premium Blue Pool Filter Parts, List Of Reasons For Geometric Proofs Reference Tables,